HIV gp120 induces, NF-kappaB dependent, HIV replication that requires procaspase 8

PLoS One. 2009;4(3):e4875. doi: 10.1371/journal.pone.0004875. Epub 2009 Mar 16.

Abstract

Background: HIV envelope glycoprotein gp120 causes cellular activation resulting in anergy, apoptosis, proinflammatory cytokine production, and through an unknown mechanism, enhanced HIV replication.

Methodology/principal findings: We describe that the signals which promote apoptosis are also responsible for the enhanced HIV replication. Specifically, we demonstrate that the caspase 8 cleavage fragment Caspase8p43, activates p50/p65 Nuclear Factor kappaB (NF-kappaB), in a manner which is inhibited by dominant negative IkappaBalpha. This caspase 8 dependent NF-kappaB activation occurs following stimulation with gp120, TNF, or CD3/CD28 crosslinking, but these treatments do not activate NF-kappaB in cells deficient in caspase 8. The Casp8p43 cleavage fragment also transactivates the HIV LTR through NF-kappaB, and the absence of caspase 8 following HIV infection greatly inhibits HIV replication.

Conclusion/significance: Gp120 induced caspase 8 dependent NF-kappaB activation is a novel pathway of HIV replication which increases understanding of the biology of T-cell death, as well as having implications for understanding treatment and prevention of HIV infection.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis
  • Base Sequence
  • Caspase 8 / metabolism*
  • Cell Line
  • DNA Primers
  • Electrophoretic Mobility Shift Assay
  • HIV Envelope Protein gp120 / physiology*
  • HIV Long Terminal Repeat
  • HIV-1 / physiology*
  • Humans
  • Hydrolysis
  • NF-kappa B / physiology*
  • Virus Replication*

Substances

  • DNA Primers
  • HIV Envelope Protein gp120
  • NF-kappa B
  • Caspase 8